Sign inGet started

EGLT

Egalet CorpCIK 1586105 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26

AI insights for EGLT PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for EGLT
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
TIMMINS MEGAN C.General Counsel10$0$02019-03-26
Shea Patrick MChief Commercial Officer16$0$24.4K2019-03-26
Strobeck MarkChief Operating Officer33$0$949.5K2019-03-26
Radie Robert SPresident and CEO42$0$1.85M2019-03-26
Smiley Andrea HeslinDirector4$0$02019-01-31
Hochberg ElaineDirector4$0$02019-01-31
NICOLAIDES NICHOLAS CDirector10$0$02019-01-31
CARLIN BARBARAChief Accounting Officer12$0$02019-01-31
Varian JohnDirector2$0$02019-01-31
Walbert Timothy PDirector14$0$02019-01-31
WEAVER GREGORY LDirector14$0$02019-01-31
ROCHE ROBERT P JRDirector6$0$02019-01-31
OSBORN JOHN EDirector10$0$02019-01-31
Musial StanChief Financial Officer22$0$838.0K2018-06-13
VARKI PAULSVP, GC & Chief Compliance Off6$0$18.3K2017-07-03
Dayno Jeffrey M.Chief Medical Officer15$0$57.9K2017-06-08
Melloy Deanne F.Chief Commercial Officer7$0$72.2K2016-04-05
LINDHARDT KARSTENVP, Research & Development3$0$02016-01-04
AGUIAR-LUCANDER RENEEDirector5$1000.0K$02014-02-11
Danish Biotech SPV I P/S10% Owner18$2.87M$02014-02-11
SEGERROS ANDREAS RutgerDirector, 10% Owner11$1.60M$02014-02-11
SUNSTONE LIFE SCIENCE VENTURES FUND II K/S10% Owner11$1.60M$02014-02-11
Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.10% Owner5$4.45M$02014-02-11
Index Ventures III (Delaware) L.P.10% Owner52$0$02014-02-11
Atlas Venture Fund VII L P10% Owner11$500.0K$02014-02-11
FORMELA JEAN FRANCOISDirector, 10% Owner11$500.0K$02014-02-11

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Radie Robert SPresident and CEO A Award2019-03-262019-03-28172,000— $0172,000SEC↗
Radie Robert SPresident and CEO A Award2019-03-262019-03-2866,000— $0238,000SEC↗
Strobeck MarkChief Operating Officer A Award2019-03-262019-03-2887,000— $087,000SEC↗
Strobeck MarkChief Operating Officer A Award2019-03-262019-03-2833,000— $0120,000SEC↗
Shea Patrick MChief Commercial Officer A Award2019-03-262019-03-2825,000— $090,000SEC↗
Shea Patrick MChief Commercial Officer A Award2019-03-262019-03-2865,000— $065,000SEC↗
TIMMINS MEGAN C.General Counsel A Award2019-03-262019-03-2843,000— $043,000SEC↗
TIMMINS MEGAN C.General Counsel A Award2019-03-262019-03-2820,000— $063,000SEC↗
Radie Robert SPresident and CEO D To issuer deriv2019-01-312019-02-04150,000— $00SEC↗
Radie Robert SPresident and CEO D To issuer deriv2019-01-312019-02-0450,000— $00SEC↗
Radie Robert SPresident and CEO D To issuer deriv2019-01-312019-02-04100,000— $00SEC↗
Radie Robert SPresident and CEO D To issuer deriv2019-01-312019-02-04150,000— $00SEC↗
Radie Robert SPresident and CEO D To issuer deriv2019-01-312019-02-04265,000— $00SEC↗
Strobeck MarkChief Operating Officer D To issuer deriv2019-01-312019-02-04100,000— $00SEC↗
Strobeck MarkChief Operating Officer D To issuer deriv2019-01-312019-02-04100,000— $00SEC↗
Strobeck MarkChief Operating Officer D To issuer deriv2019-01-312019-02-04115,000— $00SEC↗
Strobeck MarkChief Operating Officer D To issuer deriv2019-01-312019-02-0440,000— $00SEC↗
CARLIN BARBARAChief Accounting Officer D To issuer deriv2019-01-312019-02-0410,000— $00SEC↗
CARLIN BARBARAChief Accounting Officer D To issuer deriv2019-01-312019-02-0444,000— $00SEC↗
CARLIN BARBARAChief Accounting Officer D To issuer deriv2019-01-312019-02-0417,500— $00SEC↗
CARLIN BARBARAChief Accounting Officer D To issuer deriv2019-01-312019-02-0428,000— $00SEC↗
CARLIN BARBARAChief Accounting Officer D To issuer deriv2019-01-312019-02-0430,000— $00SEC↗
TIMMINS MEGAN C.General Counsel D To issuer deriv2019-01-312019-02-0415,000— $00SEC↗
TIMMINS MEGAN C.General Counsel D To issuer deriv2019-01-312019-02-0410,000— $00SEC↗
TIMMINS MEGAN C.General Counsel D To issuer deriv2019-01-312019-02-044,375— $00SEC↗
TIMMINS MEGAN C.General Counsel D To issuer deriv2019-01-312019-02-048,500— $00SEC↗
Shea Patrick MChief Commercial Officer D To issuer deriv2019-01-312019-02-0480,000— $00SEC↗
Shea Patrick MChief Commercial Officer D To issuer deriv2019-01-312019-02-0480,000— $00SEC↗
Shea Patrick MChief Commercial Officer D To issuer deriv2019-01-312019-02-04127,500— $00SEC↗
Walbert Timothy PDirector D To issuer deriv2019-01-312019-02-0410,000— $00SEC↗
Walbert Timothy PDirector D To issuer deriv2019-01-312019-02-0420,000— $00SEC↗
Walbert Timothy PDirector D To issuer deriv2019-01-312019-02-04667— $00SEC↗
Walbert Timothy PDirector D To issuer deriv2019-01-312019-02-041,328— $00SEC↗
Walbert Timothy PDirector D To issuer deriv2019-01-312019-02-0429,666— $00SEC↗
Walbert Timothy PDirector D To issuer deriv2019-01-312019-02-0475,000— $00SEC↗
Walbert Timothy PDirector D To issuer deriv2019-01-312019-02-0458,133— $00SEC↗
Varian JohnDirector D To issuer deriv2019-01-312019-02-04110,000— $00SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2019-01-312019-02-0475,000— $00SEC↗
Smiley Andrea HeslinDirector D To issuer deriv2019-01-312019-02-0451,817— $00SEC↗
Hochberg ElaineDirector D To issuer deriv2019-01-312019-02-0475,000— $00SEC↗
Hochberg ElaineDirector D To issuer deriv2019-01-312019-02-0451,817— $00SEC↗
OSBORN JOHN EDirector D To issuer deriv2019-01-312019-02-0475,000— $00SEC↗
OSBORN JOHN EDirector D To issuer deriv2019-01-312019-02-0420,000— $00SEC↗
OSBORN JOHN EDirector D To issuer deriv2019-01-312019-02-0410,000— $00SEC↗
OSBORN JOHN EDirector D To issuer deriv2019-01-312019-02-0429,666— $00SEC↗
OSBORN JOHN EDirector D To issuer deriv2019-01-312019-02-0458,133— $00SEC↗
WEAVER GREGORY LDirector D To issuer deriv2019-01-312019-02-0410,000— $00SEC↗
WEAVER GREGORY LDirector D To issuer deriv2019-01-312019-02-04667— $00SEC↗
WEAVER GREGORY LDirector D To issuer deriv2019-01-312019-02-042,083— $00SEC↗
WEAVER GREGORY LDirector D To issuer deriv2019-01-312019-02-0420,000— $00SEC↗
WEAVER GREGORY LDirector D To issuer deriv2019-01-312019-02-0475,000— $00SEC↗
WEAVER GREGORY LDirector D To issuer deriv2019-01-312019-02-0458,133— $00SEC↗
WEAVER GREGORY LDirector D To issuer deriv2019-01-312019-02-0429,666— $00SEC↗
NICOLAIDES NICHOLAS CDirector D To issuer deriv2019-01-312019-02-0410,000— $00SEC↗
NICOLAIDES NICHOLAS CDirector D To issuer deriv2019-01-312019-02-0420,000— $00SEC↗
NICOLAIDES NICHOLAS CDirector D To issuer deriv2019-01-312019-02-0429,666— $00SEC↗
NICOLAIDES NICHOLAS CDirector D To issuer deriv2019-01-312019-02-0458,133— $00SEC↗
NICOLAIDES NICHOLAS CDirector D To issuer deriv2019-01-312019-02-0475,000— $00SEC↗
ROCHE ROBERT P JRDirector D To issuer deriv2019-01-312019-02-0426,282— $00SEC↗
ROCHE ROBERT P JRDirector D To issuer deriv2019-01-312019-02-0475,000— $00SEC↗
ROCHE ROBERT P JRDirector D To issuer deriv2019-01-312019-02-0458,133— $00SEC↗
Radie Robert SPresident and CEO D To issuer2019-01-312019-02-04834,900— $00SEC↗
Radie Robert SPresident and CEO D To issuer2019-01-312019-02-04100,000— $00SEC↗
Strobeck MarkChief Operating Officer D To issuer2019-01-312019-02-0480,000— $00SEC↗
Strobeck MarkChief Operating Officer D To issuer2019-01-312019-02-04237,080— $00SEC↗
CARLIN BARBARAChief Accounting Officer D To issuer2019-01-312019-02-0480,000— $00SEC↗
CARLIN BARBARAChief Accounting Officer D To issuer2019-01-312019-02-04105,923— $00SEC↗
TIMMINS MEGAN C.General Counsel D To issuer2019-01-312019-02-0480,000— $00SEC↗
TIMMINS MEGAN C.General Counsel D To issuer2019-01-312019-02-04126,500— $00SEC↗
Shea Patrick MChief Commercial Officer D To issuer2019-01-312019-02-04187,020— $00SEC↗
Shea Patrick MChief Commercial Officer D To issuer2019-01-312019-02-0480,000— $00SEC↗
Walbert Timothy PDirector D To issuer2019-01-312019-02-04150— $00SEC↗
Varian JohnDirector A Award deriv2018-07-022018-07-02110,000— $0110,000SEC↗
Radie Robert SPresident and CEO A Award2018-06-132018-06-15500,000— $0834,900SEC↗
Musial StanChief Financial Officer A Award2018-06-132018-06-15225,000— $0347,407SEC↗
Strobeck MarkChief Operating Officer A Award2018-06-132018-06-15225,000— $0317,080SEC↗
Shea Patrick MChief Commercial Officer A Award2018-06-132018-06-15150,000— $0267,020SEC↗
TIMMINS MEGAN C.General Counsel A Award2018-06-132018-06-15125,000— $0206,500SEC↗
CARLIN BARBARAChief Accounting Officer A Award2018-06-132018-06-15100,000— $0185,923SEC↗
NICOLAIDES NICHOLAS CDirector A Award deriv2018-05-142018-05-1575,000— $075,000SEC↗
Hochberg ElaineDirector A Award deriv2018-05-142018-05-1575,000— $075,000SEC↗
ROCHE ROBERT P JRDirector A Award deriv2018-05-142018-05-1575,000— $075,000SEC↗
Smiley Andrea HeslinDirector A Award deriv2018-05-142018-05-1575,000— $075,000SEC↗
OSBORN JOHN EDirector A Award deriv2018-05-142018-05-1575,000— $075,000SEC↗
Walbert Timothy PDirector A Award deriv2018-05-142018-05-1575,000— $075,000SEC↗
WEAVER GREGORY LDirector A Award deriv2018-05-142018-05-1575,000— $075,000SEC↗
TIMMINS MEGAN C.General Counsel A Award2018-03-062018-03-0880,000— $081,500SEC↗
Radie Robert SPresident and CEO A Award2018-03-062018-03-08100,000— $0334,900SEC↗
Musial StanChief Financial Officer A Award2018-03-062018-03-0880,000— $0122,407SEC↗
Strobeck MarkChief Operating Officer A Award2018-03-062018-03-0880,000— $092,080SEC↗
Shea Patrick MChief Commercial Officer A Award2018-03-062018-03-0880,000— $0117,020SEC↗
CARLIN BARBARAChief Accounting Officer A Award2018-03-062018-03-0880,000— $085,923SEC↗
Shea Patrick MChief Commercial Officer S Sale2018-01-022018-01-03910$1.00 $91037,020SEC↗
Shea Patrick MChief Commercial Officer S Sale2017-10-022017-10-03910$1.30 $1.2K37,930SEC↗
Strobeck MarkChief Operating Officer S Sale2017-10-022017-10-038,700$1.29 $11.2K12,080SEC↗
VARKI PAULSVP, GC & Chief Compliance O S Sale2017-07-032017-07-06806$2.35 $1.9K29,514SEC↗
Shea Patrick MChief Commercial Officer S Sale2017-07-032017-07-06910$2.35 $2.1K38,840SEC↗
Musial StanChief Financial Officer S Sale2017-07-032017-07-063,480$2.36 $8.2K42,407SEC↗
Strobeck MarkChief Operating Officer S Sale2017-06-302017-07-058,700$2.39 $20.8K20,780SEC↗
Walbert Timothy PDirector A Award deriv2017-06-082017-06-1258,133— $058,133SEC↗
NICOLAIDES NICHOLAS CDirector A Award deriv2017-06-082017-06-1258,133— $058,133SEC↗
OSBORN JOHN EDirector A Award deriv2017-06-082017-06-1258,133— $058,133SEC↗
ROCHE ROBERT P JRDirector A Award deriv2017-06-082017-06-1258,133— $058,133SEC↗
WEAVER GREGORY LDirector A Award deriv2017-06-082017-06-1258,133— $058,133SEC↗
Radie Robert SPresident and CEO A Award deriv2017-06-082017-06-12150,000— $0150,000SEC↗
Musial StanChief Financial Officer A Award deriv2017-06-082017-06-12100,000— $0100,000SEC↗
Strobeck MarkChief Operating Officer A Award deriv2017-06-082017-06-12100,000— $0100,000SEC↗
Dayno Jeffrey M.Chief Medical Officer A Award deriv2017-06-082017-06-1280,000— $080,000SEC↗
Shea Patrick MChief Commercial Officer A Award deriv2017-06-082017-06-1280,000— $080,000SEC↗
VARKI PAULSVP, GC & Chief Compliance O A Award deriv2017-06-082017-06-1250,000— $050,000SEC↗
CARLIN BARBARAChief Accounting Officer A Award deriv2017-06-082017-06-1230,000— $030,000SEC↗
Smiley Andrea HeslinDirector A Award deriv2017-05-012017-05-0251,817— $051,817SEC↗
Hochberg ElaineDirector A Award deriv2017-05-012017-05-0251,817— $051,817SEC↗
VARKI PAULSVP, GC & Chief Compliance O S Sale2017-04-032017-04-04806$5.05 $4.1K28,820SEC↗
Musial StanChief Financial Officer S Sale2017-04-032017-04-058,613$5.04 $43.4K45,887SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2017-03-312017-04-04536$5.16 $2.8K18,212SEC↗
Strobeck MarkChief Operating Officer S Sale2017-03-312017-03-318,700$5.11 $44.5K29,480SEC↗
Shea Patrick MChief Commercial Officer S Sale2017-03-202017-03-214,250$4.75 $20.2K38,250SEC↗
ROCHE ROBERT P JRDirector A Award deriv2017-01-032017-01-0426,282— $026,282SEC↗
Musial StanChief Financial Officer S Sale2017-01-032017-01-0413,480$7.73 $104.2K54,500SEC↗
VARKI PAULSVP, GC & Chief Compliance O S Sale2017-01-032017-01-04806$7.75 $6.2K29,626SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2017-01-032017-01-04536$7.75 $4.2K18,748SEC↗
Strobeck MarkChief Operating Officer S Sale2016-12-302017-01-048,700$7.81 $67.9K38,180SEC↗
CARLIN BARBARAChief Accounting Officer A Award deriv2016-12-202016-12-2028,500— $028,500SEC↗
Radie Robert SPresident and CEO A Award deriv2016-12-122016-12-1350,000— $050,000SEC↗
Radie Robert SPresident and CEO A Award deriv2016-12-062016-12-08150,000— $0150,000SEC↗
Musial StanChief Financial Officer A Award deriv2016-12-062016-12-08100,000— $0100,000SEC↗
Strobeck MarkChief Operating Officer A Award deriv2016-12-062016-12-08100,000— $0100,000SEC↗
Dayno Jeffrey M.Chief Medical Officer A Award deriv2016-12-062016-12-0880,000— $080,000SEC↗
Shea Patrick MChief Commercial Officer A Award deriv2016-12-062016-12-0880,000— $080,000SEC↗
VARKI PAULSVP, GC & Chief Compliance O A Award deriv2016-12-062016-12-0850,000— $050,000SEC↗
Shea Patrick MChief Commercial Officer A Award deriv2016-10-032016-10-04127,500— $0127,500SEC↗
Musial StanChief Financial Officer S Sale2016-10-032016-10-0413,480$7.47 $100.7K67,980SEC↗
Radie Robert SPresident and CEO S Sale2016-10-032016-10-0415,000$7.47 $112.0K234,900SEC↗
VARKI PAULSVP, GC & Chief Compliance O S Sale2016-10-032016-10-04806$7.56 $6.1K30,432SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2016-09-302016-10-03536$7.69 $4.1K19,284SEC↗
Strobeck MarkChief Operating Officer S Sale2016-09-302016-10-038,700$7.55 $65.7K71,880SEC↗
Strobeck MarkChief Operating Officer S Sale2016-09-302016-10-0325,000$7.59 $189.8K46,880SEC↗
Radie Robert SPresident and CEO S Sale2016-07-062016-07-065,000$5.02 $25.1K249,900SEC↗
Musial StanChief Financial Officer S Sale2016-07-052016-07-063,480$5.05 $17.6K81,460SEC↗
Radie Robert SPresident and CEO S Sale2016-07-052016-07-065,000$4.94 $24.7K254,900SEC↗
Musial StanChief Financial Officer S Sale2016-07-012016-07-0610,000$5.06 $50.6K84,940SEC↗
Radie Robert SPresident and CEO S Sale2016-07-012016-07-065,000$5.07 $25.4K259,900SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2016-06-302016-07-05536$4.65 $2.5K19,820SEC↗
Strobeck MarkChief Business Officer S Sale2016-06-302016-07-058,700$4.68 $40.7K80,580SEC↗
OSBORN JOHN EDirector A Award deriv2016-06-152016-07-2229,666— $029,666SEC↗
NICOLAIDES NICHOLAS CDirector A Award deriv2016-06-152016-07-2229,666— $029,666SEC↗
Radie Robert SPresident and CEO A Award deriv2016-06-152016-06-17265,000$8.59 $2.28M265,000SEC↗
WEAVER GREGORY LDirector A Award deriv2016-06-152016-06-1729,666$4.98 $147.7K29,666SEC↗
Walbert Timothy PDirector A Award deriv2016-06-152016-06-1729,666$4.98 $147.7K29,666SEC↗
Melloy Deanne F.Chief Commercial Officer S Sale2016-04-052016-04-06860$6.96 $6.0K33,420SEC↗
Radie Robert SPresident and CEO S Sale2016-04-052016-04-065,000$6.99 $35.0K264,900SEC↗
Radie Robert SPresident and CEO S Sale2016-04-042016-04-055,000$6.99 $35.0K269,900SEC↗
Musial StanChief Financial Officer S Sale2016-04-012016-04-043,480$7.02 $24.4K94,940SEC↗
Musial StanChief Financial Officer S Sale2016-04-012016-04-043,480$7.02 $24.4K94,940SEC↗
Radie Robert SPresident and CEO S Sale2016-04-012016-04-055,000$6.94 $34.7K274,900SEC↗
Strobeck MarkChief Business Officer S Sale2016-03-312016-04-048,700$6.70 $58.3K89,280SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2016-03-312016-04-04536$6.72 $3.6K20,356SEC↗
Radie Robert SPresident and CEO S Sale2016-01-112016-01-123,000$9.65 $28.9K279,900SEC↗
Radie Robert SPresident and CEO S Sale2016-01-082016-01-124,000$9.69 $38.8K282,900SEC↗
Radie Robert SPresident and CEO S Sale2016-01-072016-01-123,000$9.61 $28.8K286,900SEC↗
Radie Robert SPresident and CEO S Sale2016-01-062016-01-072,100$10.16 $21.3K298,900SEC↗
Radie Robert SPresident and CEO S Sale2016-01-052016-01-071,400$11.11 $15.6K301,000SEC↗
LINDHARDT KARSTENVP, Research & Development A Award deriv2016-01-042016-07-0640,000$10.98 $439.2K40,000SEC↗
CARLIN BARBARAChief Accounting Officer A Award deriv2016-01-042016-01-1117,500— $017,500SEC↗
Musial StanChief Financial Officer S Sale2016-01-042016-01-053,480$10.68 $37.2K98,420SEC↗
Melloy Deanne F.Chief Commercial Officer S Sale2016-01-042016-01-05860$10.45 $9.0K34,280SEC↗
Radie Robert SPresident and CEO S Sale2016-01-042016-01-071,500$10.47 $15.7K302,400SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2015-12-312016-01-05536$10.40 $5.6K20,892SEC↗
Strobeck MarkChief Business Officer S Sale2015-12-312016-01-058,700$10.40 $90.5K97,980SEC↗
Musial StanChief Financial Officer A Award deriv2015-11-202015-11-24115,000— $0115,000SEC↗
Strobeck MarkChief Business Officer A Award deriv2015-11-202015-11-24115,000— $0115,000SEC↗
Dayno Jeffrey M.Chief Medical Officer A Award deriv2015-11-202015-11-24100,000— $0100,000SEC↗
Melloy Deanne F.Chief Commercial Officer A Award deriv2015-11-202015-11-2465,000— $065,000SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2015-10-262015-10-28536$8.96 $4.8K21,428SEC↗
Melloy Deanne F.Chief Commercial Officer S Sale2015-10-062015-10-07860$11.42 $9.8K35,140SEC↗
Radie Robert SPresident and CEO S Sale2015-10-012015-10-0215,000$12.27 $184.1K303,900SEC↗
Musial StanChief Financial Officer S Sale2015-10-012015-10-028,480$12.32 $104.5K101,900SEC↗
Strobeck MarkChief Business Officer S Sale2015-09-302015-10-025,220$12.56 $65.6K106,680SEC↗
Melloy Deanne F.Chief Commercial Officer S Sale2015-07-132015-09-114,000$11.85 $47.4K36,000SEC↗
Radie Robert SPresident and CEO S Sale2015-07-082015-07-093,000$11.62 $34.9K318,900SEC↗
Radie Robert SPresident and CEO S Sale2015-07-072015-07-093,000$12.31 $36.9K321,900SEC↗
Radie Robert SPresident and CEO S Sale2015-07-062015-07-063,000$11.94 $35.8K324,900SEC↗
Radie Robert SPresident and CEO S Sale2015-07-022015-07-063,000$12.44 $37.3K327,900SEC↗
Musial StanChief Financial Officer S Sale2015-07-012015-07-028,480$13.20 $111.9K110,380SEC↗
Strobeck MarkChief Business Officer S Sale2015-07-012015-07-0210,440$12.98 $135.5K111,900SEC↗
Radie Robert SPresident and CEO S Sale2015-07-012015-07-063,000$13.22 $39.7K330,900SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2015-06-302015-07-02536$15.32 $8.2K21,964SEC↗
OSBORN JOHN EDirector A Award deriv2015-06-102016-07-2210,000— $010,000SEC↗
NICOLAIDES NICHOLAS CDirector A Award deriv2015-06-102016-07-2210,000— $010,000SEC↗
Walbert Timothy PDirector A Award deriv2015-06-102016-06-1710,000$12.08 $120.8K10,000SEC↗
WEAVER GREGORY LDirector A Award deriv2015-06-102016-06-1710,000$12.08 $120.8K10,000SEC↗
OSBORN JOHN EDirector A Award deriv2015-04-102016-07-2220,000— $020,000SEC↗
NICOLAIDES NICHOLAS CDirector A Award deriv2015-04-102016-07-2220,000— $020,000SEC↗
Musial StanChief Financial Officer S Sale2015-04-012015-04-023,480$11.35 $39.5K118,860SEC↗
Radie Robert SPresident and CEO S Sale2015-04-012015-04-0211,130$11.25 $125.2K333,900SEC↗
Dayno Jeffrey M.Chief Medical Officer S Sale2015-02-032015-02-032,500$8.87 $22.2K22,500SEC↗
Melloy Deanne F.Chief Commercial Officer A Award deriv2015-01-022015-01-15120,000— $0120,000SEC↗
Strobeck MarkChief Business Officer S Sale2015-01-022015-01-053,480$5.09 $17.7K122,340SEC↗
Musial StanChief Financial Officer S Sale2015-01-022015-01-053,480$5.05 $17.6K122,340SEC↗
Radie Robert SPresident and CEO S Sale2015-01-022015-01-0511,130$5.11 $56.9K345,030SEC↗
Melloy Deanne F.Chief Commercial Officer A Award2015-01-022015-01-1540,000— $040,000SEC↗
Radie Robert SPresident and CEO A Award deriv2014-12-042014-12-08100,000— $0100,000SEC↗
Musial StanChief Financial Officer A Award deriv2014-12-042014-12-0840,000— $040,000SEC↗
Dayno Jeffrey M.Chief Medical Officer A Award deriv2014-12-042014-12-0860,000— $060,000SEC↗
Strobeck MarkChief Business Officer A Award deriv2014-12-042014-12-0840,000— $040,000SEC↗
LINDHARDT KARSTENVP, Research & Development A Award deriv2014-12-042014-12-0840,000— $040,000SEC↗
Walbert Timothy PDirector A Award deriv2014-09-302014-10-0120,000— $020,000SEC↗
WEAVER GREGORY LDirector A Award deriv2014-09-302014-10-0120,000— $020,000SEC↗
Radie Robert SPresident and CEO S Sale2014-09-102014-09-1120,020$9.68 $193.8K356,160SEC↗
Radie Robert SPresident and CEO S Sale2014-09-092014-09-1120,020$9.54 $191.0K376,180SEC↗
Radie Robert SPresident and CEO S Sale2014-09-082014-09-0919,000$9.66 $183.5K396,200SEC↗
Radie Robert SPresident and CEO S Sale2014-09-052014-09-0930,000$9.79 $293.7K415,200SEC↗
Strobeck MarkChief Business Officer S Sale2014-08-132014-08-142,635$9.15 $24.1K125,280SEC↗
Strobeck MarkChief Business Officer S Sale2014-08-122014-08-142,500$9.26 $23.1K127,915SEC↗
Strobeck MarkChief Business Officer S Sale2014-08-112014-08-123,300$10.16 $33.5K130,415SEC↗
Strobeck MarkChief Business Officer S Sale2014-08-082014-08-122,400$10.45 $25.1K133,715SEC↗
Musial StanChief Financial Officer S Sale2014-08-072014-08-086,272$11.03 $69.2K125,820SEC↗
Strobeck MarkChief Business Officer S Sale2014-08-072014-08-081,200$10.90 $13.1K136,115SEC↗
Dayno Jeffrey M.Chief Medical Officer A Award deriv2014-08-062014-08-0775,000— $075,000SEC↗
Dayno Jeffrey M.Chief Medical Officer A Award2014-08-062014-08-0725,000— $025,000SEC↗
Musial StanChief Financial Officer S Sale2014-08-062014-08-087,648$11.06 $84.6K131,552SEC↗
Strobeck MarkChief Business Officer S Sale2014-08-062014-08-081,885$11.89 $22.4K137,315SEC↗
WEAVER GREGORY LDirector A Award deriv2014-06-092014-06-11667— $0667SEC↗
Walbert Timothy PDirector A Award deriv2014-06-092014-06-11667— $0667SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion deriv2014-02-112014-02-12863,754— $00SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion deriv2014-02-112014-02-12833,098— $00SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner X Exercise deriv2014-02-112014-02-1230,000— $00SEC↗
Atlas Venture Fund VII L P10% Owner X Exercise deriv2014-02-112014-02-1230,000— $00SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion deriv2014-02-112014-02-12863,754— $00SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion deriv2014-02-112014-02-12833,098— $00SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner X Exercise deriv2014-02-112014-02-1296,000— $00SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner C Conversion deriv2014-02-112014-02-12736,826— $00SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner C Conversion deriv2014-02-112014-02-12416,812— $00SEC↗
SEGERROS ANDREAS RutgerDirector, 10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
SEGERROS ANDREAS RutgerDirector, 10% Owner C Conversion deriv2014-02-112014-02-12416,812— $00SEC↗
SEGERROS ANDREAS RutgerDirector, 10% Owner C Conversion deriv2014-02-112014-02-120— $00SEC↗
SEGERROS ANDREAS RutgerDirector, 10% Owner X Exercise deriv2014-02-112014-02-1296,000— $00SEC↗
SEGERROS ANDREAS RutgerDirector, 10% Owner C Conversion deriv2014-02-112014-02-12736,826— $00SEC↗
AGUIAR-LUCANDER RENEEDirector X Exercise deriv2014-02-112014-02-1260,000— $00SEC↗
AGUIAR-LUCANDER RENEEDirector C Conversion deriv2014-02-112014-02-120— $00SEC↗
Danish Biotech SPV I P/S10% Owner C Conversion deriv2014-02-112014-02-13251,125— $00SEC↗
Danish Biotech SPV I P/S10% Owner X Exercise deriv2014-02-112014-02-130— $00SEC↗
Danish Biotech SPV I P/S10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Danish Biotech SPV I P/S10% Owner C Conversion deriv2014-02-112014-02-1360,000— $00SEC↗
Danish Biotech SPV I P/S10% Owner X Exercise deriv2014-02-112014-02-13112,500— $00SEC↗
Danish Biotech SPV I P/S10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Danish Biotech SPV I P/S10% Owner C Conversion deriv2014-02-112014-02-13438,364— $00SEC↗
Danish Biotech SPV I P/S10% Owner C Conversion deriv2014-02-112014-02-13523,799— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-135,390— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-1347,298— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-1389,800— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-13169,372— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-13302,576— $00SEC↗
Index Ventures III (Delaware) 10% Owner X Exercise deriv2014-02-112014-02-1323,284— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-1344,207— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-1383,377— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-13148,950— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-133,685— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-131,600— $00SEC↗
Index Ventures III (Delaware) 10% Owner X Exercise deriv2014-02-112014-02-133,017— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-13192,076— $00SEC↗
Index Ventures III (Delaware) 10% Owner X Exercise deriv2014-02-112014-02-133,500— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-131,093— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-132,062— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner X Exercise deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner X Exercise deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-130— $00SEC↗
Index Ventures III (Delaware) 10% Owner C Conversion deriv2014-02-112014-02-13842— $00SEC↗
Radie Robert SPresident and CEO A Award2014-02-112014-02-12445,200— $0445,200SEC↗
Musial StanChief Financial Officer A Award2014-02-112014-02-12139,200— $0139,200SEC↗
LINDHARDT KARSTENVP, Research & Development A Award2014-02-112014-02-12139,200— $0139,200SEC↗
Strobeck MarkChief Business Officer A Award2014-02-112014-02-12139,200— $0139,200SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion2014-02-112014-02-1285,620$6.00 $513.7K2,110,555SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner P Buy2014-02-112014-02-1241,667$12.00 $500.0K2,152,222SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion2014-02-112014-02-12298,083$6.00 $1.79M2,024,935SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner X Exercise2014-02-112014-02-1230,000— $01,726,852SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion2014-02-112014-02-12863,754— $01,696,852SEC↗
FORMELA JEAN FRANCOISDirector, 10% Owner C Conversion2014-02-112014-02-12833,098— $0833,098SEC↗
Atlas Venture Fund VII L P10% Owner P Buy2014-02-112014-02-1241,667$12.00 $500.0K2,152,222SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion2014-02-112014-02-1285,620$6.00 $513.7K2,110,555SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion2014-02-112014-02-12298,083$6.00 $1.79M2,024,935SEC↗
Atlas Venture Fund VII L P10% Owner X Exercise2014-02-112014-02-1230,000— $01,726,852SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion2014-02-112014-02-12863,754— $01,696,852SEC↗
Atlas Venture Fund VII L P10% Owner C Conversion2014-02-112014-02-12833,098— $0833,098SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner X Exercise2014-02-112014-02-1296,000— $01,249,638SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner C Conversion2014-02-112014-02-12736,826— $01,153,638SEC↗
SUNSTONE LIFE SCIENCE VENTURES10% Owner C Conversion2014-02-112014-02-12416,812— $0416,812SEC↗